BIFIDO Co., Ltd. (KOSDAQ:238200)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,845.00
-30.00 (-1.04%)
At close: Mar 6, 2026
-6.26%
Market Cap 22.58B
Revenue (ttm) 18.65B
Net Income (ttm) -246.68M
Shares Out 8.18M
EPS (ttm) -30.17
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 24,584
Average Volume 29,053
Open 2,875.00
Previous Close 2,875.00
Day's Range 2,695.00 - 2,875.00
52-Week Range 2,460.00 - 4,390.00
Beta 1.13
RSI 36.10
Earnings Date Mar 13, 2026

About BIFIDO

BIFIDO Co., Ltd. produces probiotics-based products in South Korea and internationally. It offers bifidobacterium strain products, such as BGN4 for immune modulating; BORI used to treat rotavirus infection in infants; and AD011 for general intestinal health problems. The company was founded in 1999 and is headquartered in Hongcheon-eup, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1999
Employees 83
Stock Exchange KOSDAQ
Ticker Symbol 238200
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.